AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006
Mar 13, 2006
30339_dirs_2006-03-13_fe919464-9a89-4521-b0d8-0b99300ae558.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-24
Reporting Person: FEDERICI WILLIAM J (VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2006-02-24 | Common Stock | A | 6557 | — | Acquired | 30620.0014 | Direct |
| 2006-02-24 | Common Stock | A | 1844.3491 | $32.5850 | Acquired | 32464.3505 | Direct |
| 2006-02-24 | Common Stock | A | 1600 | — | Acquired | 34064.3505 | Direct |
| 2006-02-24 | Common Stock | A | 12.95 | $32.7800 | Acquired | 8200.1412 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2006-02-24 | Stock Option (Right to Buy) | $32.5850 | A | 19183 | Acquired | 2016-02-24 | Common Stock (19183.00) | Direct |
Footnotes
F1: Bonus and incentive shares granted on 2/24/06.
F2: Additional amount of shares due to achieving above targeted amount for first performance period of 3/7/05 Performance Vested Restricted Share grant.
F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
F4: Amount in error as the incorrect price was used to calculate the number of shares.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12